ClinicalTrials.govpublic full text
CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation
lymphoma, b-cell, leukemia, b-cell, minimal disease, residual, car-t, minimal residual disease, b cell maliganacy, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801426
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.